Microfluidics said that the industry and academic research teams are able to achieve superior nanoemulsions, nanosuspensions, nanoencapsulation and protein yield while minimizing quantities of limited and expensive materials used.
The LV1 generates incredible levels of shear, up to 12.25 million sec-1, which are orders of magnitude greater than other technologies. The increased shear enables biotechnology customers, for example, to achieve high cell rupture rates for challenging applications (yeast) in a fraction of the time than can be achieved using other technologies. In addition, media and chemical-free coupling, along with effective cooling, improves protein yield and makes each ml of material more valuable.
The company said that every Microfluidizer processor has the fixed-geometry interaction chamber and a constant pressure pumping system, which together ensure the effective and uniform processing performance.
Unlike other technologies, results achieved on the LV1 are scalable through lab, clinical trial and pilot/production volumes. Producing pressures up to 2069 bar (30,000 psi) with low power consumption, the LV1 is a highly efficient processor with a small footprint and spectacularly quiet operation. Like all Microfluidizer processors, it is easy to use and clean, and results are scalable to production volumes.
Michael Ferrara, president and CEO of Microfluidics, said: “Customers have told us that they’ve been waiting for a product like the LV1. By lowering the minimum volume requirements of our gold standard Microfluidizer processors, our engineers have made smaller particles and efficient cell rupture more accessible to innovative research teams. The LV1 is an exclusive alternative for an industry continually seeking to improve product quality and consistency without exhausting their resources.”